source
- STAT+: FDA leadership shakeup widens following Makary’s departureThe acting director of the FDA’s drug center, Tracy Beth Høeg, is leaving the agency. The news come days after Commissioner Marty Makary handed in his resignation.STAT · 2mo ago↗ source
- Dr Cirstea on Sequencing Considerations in R/R Multiple MyelomaDiana Cirstea, MD, discusses sequencing considerations in relapsed/refractory multiple myeloma in the era of T-cell–redirecting therapies.onclive · 2mo ago↗ source
- Dr Hafron on the FDA Approval of Adjuvant Atezolizumab in MRD+ MIBCJason Hafron, MD, discusses the significance of the FDA approval of adjuvant atezolizumab for MRD+ muscle-invasive bladder cancer.onclive · 2mo ago↗ source